Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 40 Pancreatic Neoplasms 17 Breast Neoplasms 17 Esophageal Neoplasms 14 Neoplasms 13 Stomach Neoplasms 12 Lung Neoplasms 12 Triple Negative Breast Neoplasms 11 Rectal Neoplasms 11 Neoplasm Metastasis 11 Esophageal Squamous Cell Carcinoma 11 Uterine Cervical Neoplasms 10 Colorectal Neoplasms 10 Small Cell Lung Carcinoma 9 Ovarian Neoplasms 9 Head and Neck Neoplasms 7 Squamous Cell Carcinoma of Head and Neck 5 Sarcoma 5 Nasopharyngeal Carcinoma 5 Leukemia, Myeloid, Acute 5 Endometrial Neoplasms 5 Recurrence 4 NSCLC 4 Mouth Neoplasms 4 Colonic Neoplasms 4 Lymphoma 3 Glioma 3 Cholangiocarcinoma 3 Adenocarcinoma Of Esophagus 3 Urinary Bladder Neoplasms 2

Interventions

famitinib 1 enzalutamide 1 apalutamide 1 Prednisolone 1 Poly(ADP-ribose) Polymerase Inhibitors 1 Neoadjuvant Therapy 1 Drug Therapy 1 Abiraterone Acetate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Neoadjuvant Therapy × Drug Therapy × Clear all

NCT06913777 2025-06-06

Neoadjuvant SNF Precision Therapy Phase III

Fudan University

Phase 3 Recruiting

Neoadjuvant Therapy

Data powered by HemOnc (CC BY 4.0) Colophon ⚡